Cargando…
Second surgery for progressive glioblastoma: a multi‐centre questionnaire and cohort‐based review of clinical decision‐making and patient outcomes in current practice
PURPOSE: Glioblastoma prognosis is poor. Treatment options are limited at progression. Surgery may benefit, but no quality guidelines exist to inform patient selection. We sought to describe variations in surgical management at progression, highlight where further evidence is needed, and build towar...
Autores principales: | Brennan, P. M., Borchert, R., Coulter, C., Critchley, G. R., Hall, B., Holliman, D., Phang, I., Jefferies, S. J., Keni, S., Lee, L., Liaquat, I., Marcus, H. J., Thomson, S., Thorne, L., Vintu, M., Wiggins, A. N., Jenkinson, M. D., Erridge, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131335/ https://www.ncbi.nlm.nih.gov/pubmed/33791952 http://dx.doi.org/10.1007/s11060-021-03748-0 |
Ejemplares similares
-
Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study
por: Poon, Michael T C, et al.
Publicado: (2021) -
Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients
por: Cilibrasi, Chiara, et al.
Publicado: (2022) -
Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping
por: Lane, Rosemary, et al.
Publicado: (2019) -
Survival outcomes following craniotomy for intracranial metastases from an unknown primary
por: Gough, Melissa, et al.
Publicado: (2020) -
Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme
por: Guilfoyle, M R, et al.
Publicado: (2011)